Jun-Han Su, MD, PhD

Cover a range of SMID cap biotechnology and life sciences companies as well as support the firm's private equity investments, with a focus on neuroscience, cell and gene therapy, emerging immunology and oncology, AI-enabled drug discovery, genomics technologies, and molecular diagnostics.

Generated investment theses and supported diligence of public and private companies in the cell therapy and next-generation proteomics space

Projects in Professor Xiaowei Zhuang's Group: ● Solved the first high resolution 3D structures of full-length human chromosomes ● Developed genome-scale imaging tools to profile spatial organization and activity of chromatin in cells ● Developed multicolor CRISPR-based tools for live cell chromatin imaging Past rotations with Profs. Erin K. O'Shea (systems biology), Adam E. Cohen (biophysics/Q-State Bio), and Cigall Kadoch (cancer epigenetics/Foghorn Tx)

Led sections and teaching laboratories for the foundational course "An Integrated Introduction to Genetics, Genomics and Evolution (LifeSci 1B)"

Supported Prof. Derrick Rossi, co-founder of Moderna and Intellia Therapeutics, in teaching the course "Biomedical Entrepreneuring (SCRB 130)"

Supported the J&J Innovation team in partnerships and investments across therapeutic, medical device, and consumer sectors

Conducted diligence leading to investments in Nuvaira, a medical device company targeting COPD, and Amphivena, a T-cell engager company

Supported diligence of potential investments and new company formation in the cytokine engineering and regenerative medicine space

Reviewed the IP landscape of targeted protein degradation technologies and produced marketing materials for rare kidney disease assets

● Performed technical and commercial analyses of 12+ early stage life sciences technologies from Harvard and affiliated hospitals ● Involved in business development campaigns for Harvard's life sciences invention portfolio

Co-founded the leading non-profit life sciences society in Taiwan that helps young scientists advance their careers and connect with alumni

Supported the Director of Business Development in analyzing the commercial opportunities for the company's bicyclic peptides in oncology

Ernest Peralta Award for Best Qualifying Exam Performance (2016), Harvard Office of Technology Development Fellow (2016-2017), Simmons Award for Biological Imaging (2015, 2016), Derek Bok Center Distinction in Teaching Award (2015), Taiwan Ministry of Education Scholar (2014-2016)

Courses in Commercializing Science, Entrepreneurial Finance, and Investment Management

Chevening Scholar (2013-2014), NIH Breast Cancer Challenge Winner (2014), OneStart Europe Biotech Startup Competition Semi-finalist (2014) Master's Dissertation: Developing Bicycle Therapeutics' Drug-conjugate Program in Oncology - A Commercial Analysis of Potential Indications

Young Researcher Fellow to the Lindau Nobel Laureate Meetings (2011), National Outstanding College Youth of the Year (2011), National Taiwan University Outstanding Achievement Award (2010), GSK Medical Elite Scholar (2009), Schering-Plough Summer Research Fellow and First Prize Recipient (2009), Medical School Class President (2008), Presidential Award (Top 5% in Medicine: 2005-2009), Dean's List (Top 10% in Medicine: 2004-2010)

Clinical rotations at the Massachusetts General Hospital and the Brigham and Woman's Hospital sponsored by the Taiwan Ministry of Education Overseas Exchange Scholarship